Related Experiment Video
Updated: Jul 14, 2026

Characterization of Immune Cell-derived Extracellular Vesicles and Studying Functional Impact on Cell Environment
Published on: June 2, 2020
Cell-derived microparticles and exosomes in neuroinflammatory disorders
Lawrence L Horstman1, Wenche Jy, Alireza Minagar
1Wallace H. Coulter Platelet Laboratory, Department of Medicine, University of Miami, Miami, Florida 33136, USA.
Abstract:
All blood cells and the vascular endothelium shed microparticles (MP) from their plasma membranes when suitably stimulated, and assay of MP in patient blood has found increasing application to the monitoring of disease states. In addition, mounting evidence suggests that MP are not mere epiphenomena but play significant roles in the pathophysiology of thromboses, inflammation, and cancers. This chapter endeavors to summarize the limited number of studies thus far done on MP in neurological disorders such as multiple sclerosis (MS), transient ischemic attacks, and the neurological manifestations of antiphospholipid syndrome (APS). In addition, the chapter offers some plausible hypotheses on possible roles of MP in the pathophsyiology of these disorders, chiefly, the hypothesis that MP are indeed important participants in some neuropathologies, especially those which are ischemic in nature, but probably also inflammatory ones. The chapter also goes over the history and general principles of MP studies (e.g., assay methods and pitfalls), comparison with alternative methods (e.g., soluble markers of disease states), subclasses of MP (such as exosomes), and other topics aimed at helping readers to consider MP studies in their own clinical fields. Tables include a listing of bioactive agents known to be carried on MP, many of which were heretofore considered strictly soluble, and some of which can be transferred from cell to cell via MP vectors, for example certain cytokine receptors.
Insights
Microparticles (MP), shed from cells, are increasingly studied for their role in neurological disorders like MS and APS. Research suggests MPs may significantly contribute to the pathophysiology of these conditions, particularly ischemic and inflammatory neuropathologies.
Area of Science:
- Biomedical science
- Pathophysiology
- Neuroscience
Background:
- Microparticles (MPs) are shed from blood cells and endothelium, with increasing use in disease monitoring.
- Evidence suggests MPs play roles in thrombosis, inflammation, and cancer pathophysiology.
- Limited studies exist on MPs in neurological disorders like multiple sclerosis (MS) and antiphospholipid syndrome (APS).
Purpose of the Study:
- To summarize existing research on MPs in neurological disorders.
- To propose hypotheses on the role of MPs in neuropathologies.
- To provide an overview of MP study principles and applications.
Main Methods:
- Literature review of studies on MPs in neurological disorders.
- Discussion of MP assay methods, pitfalls, and alternative diagnostic approaches.
- Exploration of MP subclasses (e.g., exosomes) and bioactive cargo.
Main Results:
- MPs are implicated in the pathophysiology of thromboses, inflammation, and cancers.
- Hypothesized significant roles for MPs in ischemic and inflammatory neuropathologies.
- Identification of bioactive agents on MPs, including cytokine receptors, transferable between cells.
Conclusions:
- MPs are potential key players in the pathophysiology of neurological disorders.
- Further research into MP roles in conditions like MS and APS is warranted.
- Understanding MP biology can aid in developing new diagnostic and therapeutic strategies.
